Sarilumab Trial Data Shows It May Only Help Critical COVID-19 Patients
New Processes May Stick Around After the Pandemic: Q&A with Wendy Ramey, BSPharm, RPh, CSP
Data on Arthritis Drug to Treat Coronavirus Could Come within Weeks
Sanofi, Regeneron Expand Testing of Potential Coronavirus Treatment
Sarilumab Investigated to Treat COVID-19
Sanofi, Regeneron Begin Testing Arthritis Drug as Coronavirus Treatment
Otilimab Begins Phase 3 Clinical Studies for RA
Rheumatology Drugs at a Glance, Part 3: Rheumatoid Arthritis